VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $20,050,000 | +13.1% | 112,402 | +40.8% | 5.34% | +33.7% |
Q2 2015 | $17,734,000 | +26.1% | 79,830 | +12.8% | 3.99% | +11.7% |
Q1 2015 | $14,060,000 | +65.4% | 70,788 | +19.2% | 3.58% | +52.4% |
Q4 2014 | $8,499,000 | -0.2% | 59,387 | -8.5% | 2.35% | -11.6% |
Q3 2014 | $8,519,000 | -32.8% | 64,934 | -32.5% | 2.65% | -54.4% |
Q1 2014 | $12,686,000 | +58.3% | 96,227 | +40.9% | 5.82% | -2.1% |
Q4 2013 | $8,015,000 | – | 68,273 | – | 5.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |